Suppr超能文献

微小 RNA-214 通过靶向 Wnt3a 抑制肝癌细胞增殖。

MicroRNA‑214 targets Wnt3a to suppress liver cancer cell proliferation.

机构信息

Department of Health Toxicology and Hygiene Inspection, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China.

出版信息

Mol Med Rep. 2017 Nov;16(5):6920-6927. doi: 10.3892/mmr.2017.7483. Epub 2017 Sep 13.

Abstract

MicroRNAs (miRNAs/miRs) are crucial molecules that act as tumor suppressor genes or oncogenes in human cancer progression. The dysregulation of miRNA expression has been detected in liver cancer. The present study aimed to explore the molecular mechanisms by which miR‑214 affects liver cancer cell proliferation. Reverse transcription‑quantitative polymerase chain reaction was used to determine the expression of miR‑214 in liver cancer cell lines and hepatocellular carcinoma (HCC) tissues. A luciferase reporter assay was performed to determine whether Wnt3a is a target gene of miR‑214. Cell Counting kit‑8 and cell cycle analysis were used to explore the effects of miR‑214 on liver cancer cell proliferation. Immunohistochemistry was used to detect protein expression levels. Wnt3a knockdown was used to determine the function of Wnt3a in liver cancer cell proliferation. The results demonstrated that the expression levels of human miR‑214 were reduced in HCC tissues and liver cancer cell lines compared with in control tissues and cells. Overexpression of miR‑214 and Wnt3a silencing each inhibited liver cancer cell growth. Conversely, inhibition of miR‑214 promoted liver cancer cell growth. The present study indicated that miR‑214 acts as a tumor suppressor and may be considered a promising therapeutic target for the treatment of liver cancer.

摘要

微小 RNA(miRNAs/miRs)是在人类癌症进展中作为肿瘤抑制基因或癌基因发挥作用的关键分子。已经在肝癌中检测到 miRNA 表达的失调。本研究旨在探讨 miR-214 影响肝癌细胞增殖的分子机制。逆转录-定量聚合酶链反应用于确定肝癌细胞系和肝细胞癌(HCC)组织中 miR-214 的表达。荧光素酶报告基因检测用于确定 Wnt3a 是否是 miR-214 的靶基因。细胞计数试剂盒-8 和细胞周期分析用于探讨 miR-214 对肝癌细胞增殖的影响。免疫组织化学用于检测蛋白表达水平。Wnt3a 敲低用于确定 Wnt3a 在肝癌细胞增殖中的功能。结果表明,与对照组织和细胞相比,HCC 组织和肝癌细胞系中人类 miR-214 的表达水平降低。miR-214 的过表达和 Wnt3a 的沉默均抑制肝癌细胞生长。相反,抑制 miR-214 促进肝癌细胞生长。本研究表明,miR-214 作为一种肿瘤抑制因子发挥作用,可能被认为是治疗肝癌的有前途的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验